Results 181 to 190 of about 3,814,564 (336)

Terapia combinada con Trastuzumab en el tratamiento del Cáncer de mama: eficacia y efectos adversos [PDF]

open access: yes, 2015
Introducción: El cáncer de mama es el más frecuente entre la población femenina. Entre un 25-30% de los cánceres de mama son HER2-positivo. Este tipo de cáncer, se ha relacionado con una mayor agresividad clínica e histológica, mayor riesgo de ...
Hernández Martín, María Sol
core  

Bridging the gap: Multi‐stakeholder perspectives of molecular diagnostics in oncology

open access: yesMolecular Oncology, EarlyView.
Although molecular diagnostics is transforming cancer care, implementing novel technologies remains challenging. This study identifies unmet needs and technology requirements through a two‐step stakeholder involvement. Liquid biopsies for monitoring applications and predictive biomarker testing emerge as key unmet needs. Technology requirements vary by
Jorine Arnouts   +8 more
wiley   +1 more source

Gasto indirecto en pacientes con cáncer de cuello uterino sometidas a radioterapia en el centro del Perú, 2020-2021

open access: yesGaceta Mexicana de Oncolog�a
Antecedentes: Toda persona sin trabajo a causa del cáncer constituye una pérdida económica para la sociedad. Las medidas más notables para cuantificar es el costo de productividad. Objetivo: Conocer los gastos indirectos por el tratamiento de irradiación en cáncer de cuello uterino y si estos están asociados o relacionados con factores clínicos ...
openaire   +2 more sources

Adenosine‐to‐inosine editing of miR‐200b‐3p is associated with the progression of high‐grade serous ovarian cancer

open access: yesMolecular Oncology, EarlyView.
A‐to‐I editing of miRNAs, particularly miR‐200b‐3p, contributes to HGSOC progression by enhancing cancer cell proliferation, migration and 3D growth. The edited form is linked to poorer patient survival and the identification of novel molecular targets.
Magdalena Niemira   +14 more
wiley   +1 more source

Investigating the cell of origin and novel molecular targets in Merkel cell carcinoma: a historic misnomer

open access: yesMolecular Oncology, EarlyView.
This study indicates that Merkel cell carcinoma (MCC) does not originate from Merkel cells, and identifies gene, protein & cellular expression of immune‐linked and neuroendocrine markers in primary and metastatic Merkel cell carcinoma (MCC) tumor samples, linked to Merkel cell polyomavirus (MCPyV) status, with enrichment of B‐cell and other immune cell
Richie Jeremian   +10 more
wiley   +1 more source

Alimentos contra el cáncer oral [PDF]

open access: yes, 2015
El cáncer oral representa el 5% de todas las neoplasias y el 30% de los cánceres de cabeza y cuello. El porcentaje de supervivencia a los 5 años es de tan sólo el 25%, por lo que el diagnóstico y tratamiento precoces pueden salvar muchas vidas.
Chimenos Küstner, Eduardo   +2 more
core  

Integrated genomic and proteomic profiling reveals insights into chemoradiation resistance in cervical cancer

open access: yesMolecular Oncology, EarlyView.
A comprehensive genomic and proteomic analysis of cervical cancer revealed STK11 and STX3 as a potential biomarkers of chemoradiation resistance. Our study demonstrated EGFR as a therapeutic target, paving the way for precision strategies to overcome treatment failure and the DNA repair pathway as a critical mechanism of resistance.
Janani Sambath   +13 more
wiley   +1 more source

Home - About - Disclaimer - Privacy